Investigative Magnetic Resonance Imaging

Korean Society of Magnetic Resonance in Medicine (대한자기공명의과학회)
권호 표지
DOI QR코드

DOI QR Code

First-pass Stress Perfusion MR Imaging Findings of Apical Hypertrophic Cardiomyopathy: with Relation to LV Wall Thickness and Late Gadolinium-enhancement

심첨형 비후성 심근병증에서의 스트레스 부하 관류 자기공명영상 소견: 좌심실 벽 비후 정도와 지연 조영 증강 간의 관련성

  • Yoo, Jin Young (Division of Cardiovascular Imaging, Department of Radiology, Seoul National University Bundang Hospital) ;
  • Chun, Eun Ju (Division of Cardiovascular Imaging, Department of Radiology, Seoul National University Bundang Hospital) ;
  • Kim, Yeo-Koon (Division of Cardiovascular Imaging, Department of Radiology, Seoul National University Bundang Hospital) ;
  • Choi, Sang Il (Division of Cardiovascular Imaging, Department of Radiology, Seoul National University Bundang Hospital) ;
  • Choi, Dong-Ju (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital)
  • 유진영 (서울대학교 분당병원 영상의학과) ;
  • 전은주 (서울대학교 분당병원 영상의학과) ;
  • 김여군 (서울대학교 분당병원 영상의학과) ;
  • 최상일 (서울대학교 분당병원 영상의학과) ;
  • 최동주 (서울대학교 분당병원 순환기내과)
  • Received : 2014.01.12
  • Accepted : 2014.03.05
  • Published : 2014.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : To evaluate the prevalence and pattern of perfusion defect (PD) on first-pass stress perfusion MR imaging in relation with the degree of left ventricular hypertrophy (LVH) and late gadolinium-enhancement (LGE) in patients with apical hypertrophic cardiomyopathy (APH). Materials and Methods: Cardiac MR imaging with first-pass stress perfusion, cine, and LGE sequence was performed in 26 patients with APH from January 2008 to December 2012. We analyzed a total of 416 segments for LV wall thickness on end-diastolic phase of cine images, and evaluated the number of hypertrophied segment and number of consecutive hypertrophied segment (NCH). We assessed the presence or absence of PD and LGE from all patients. If there was PD, we subdivided the pattern into sporadic (sporadic-PD) or ring (ring-PD). Using univariate logistic method, we obtained the independent predictor for presence of overall PD and ring-PD. Results: PD on stress perfusion MRI was observed in 20 patients (76.9%), 12 of them (60%) showed ring-PD. Maximal LV wall thickness and number of hypertrophied segment were independent predictors for overall PD (all, p < 0.05). NCH with more than 3 segments was an additional independent factor for ring-PD. However, LGE was not statistically related with PD in patients with APH. Conclusion: About three quarters of the patients with APH showed PD, most of them represented as ring-PD. LVH degree or distribution was related with pattern of PD, however, LGE was not related with PD. Therefore, the clinical significance of PD in the patients with APH seems to be different from those with non-APH, and further comparison study between the two groups should be carried out.

목적: 심첨형 비후성 심근병증 환자에서 스트레스 부하 관류 자기공명영상을 통한 관류 결손의 빈도와 양상을 평가하고, 이를 좌심실 비대의 정도와 지연 조영 증강과 비교해 보고자 한다. 대상과 방법: 2008년 1월부터 2012년 12월까지 심초음파 및 심전도로 심첨형 비후성 심근병증을 진단받고, 스트레스 부하 관류, 영화 영상 및 지연 조영 증강 영상을 포함하는 심장 자기공명영상을 시행한 26명의 환자를 대상으로 하였다. 영화 영상에서 이완기 말에 416개 분절의 좌심실 벽 두께를 분석하였고 비후된 분절의 수와 연속하여 비후된 벽 분절의 수를 조사하였다. 또한 모든 환자에서 관류 결손과 지연 조영 증강의 유무를 평가하였다. 자기공명영상에서 관류 결손이 있을 경우, 산발형 혹은 고리형의 2가지 형태로 분류하였다. 단변량 분석을 통해 전체 관류 결손과 고리형 관류 결손에 대한 독립 변수를 산출하였다. 결과: 심첨형 비후성 심근병증의 76.9%(20명)에서 스트레스 부하 관류 자기공명영상시 관류 결손을 보였으며 이중 60% (12명)이 고리형 관류 결손을 보였다. 전체 관류 결손에 대한 독립 변수는 최대 좌심실 벽 두께와 비후된 분절의 수 였고 (p < 0.05), 고리형 관류 결손에 대한 독립 변수는 3개 이상의 연속한 비후된 분절의 수가 추가되었다. 그러나 지연 조영 증강은 관류결손과는 유의한 상관관계가 없었다. 결론: 심첨형 비후성 심근병증 환자의 4분의 3에서(75%) 관류 결손을 보였으며, 대부분이 고리형 관류 결손 형태를 보였다. 좌심실 벽의 비후 정도와 분포는 관류 결손의 형태와 관련이 있었지만 지연 조영 증강과는 유의한 상관성이 없었다. 따라서 심첨형 비후성 심근병증 환자군에서 관류 결손의 임상적 의미는 비심첨형 비후성 심근병증 환자군에서 보이는 관류결손과는 임상적 의의가 다를 것으로 보이며, 이에 대한 추후의 비교연구가 필요할 것으로 여겨진다.

Keywords

References

  1. Maron BJ, McKenna WJ, Danielson GK, et al. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines. J Am Coll Cardiol 2003;42:1687-1713 https://doi.org/10.1016/S0735-1097(03)00941-0
  2. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976;17:611-629 https://doi.org/10.1536/ihj.17.611
  3. Chun EJ, Choi SI, Jin KN, et al. Hypertrophic cardiomyopathy: Assessment with MR imaging and multidetector CT. Radiographics 2010;30:1309-1328 https://doi.org/10.1148/rg.305095074
  4. Okishige K, Sasano T, Yano K, Azegami K, Suzuki K, Itoh K. Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern Med 2001;40:396-402 https://doi.org/10.2169/internalmedicine.40.396
  5. Kusukawa J, Suwa M, Nakayama Y, et al. Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities. J Cardiol 1988;18:259-269
  6. Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004;350:1320-1327 https://doi.org/10.1056/NEJMcp030779
  7. Spirito P, Bellone P. Natural history of hypertrophic cardiomyopathy. Br Heart J 1994;72(6 Suppl):S10-12
  8. Sipola P, Lauerma K, Husso-Saastamoinen M, et al. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene. Radiology 2003;226:129-137 https://doi.org/10.1148/radiol.2261011874
  9. Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2009;2:412-424 https://doi.org/10.1161/CIRCIMAGING.109.854893
  10. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004;90:645-649 https://doi.org/10.1136/hrt.2003.014969
  11. Writing Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2013;128:e240-319 https://doi.org/10.1161/CIR.0b013e31829e8776
  12. Sorajja P, Nishimura RA, Gersh BJ, et al. Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathya long-term follow-up study. J Am Coll Cardiol 2009;54:234-241 https://doi.org/10.1016/j.jacc.2009.01.079
  13. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation 2002;105:539-542 https://doi.org/10.1161/hc0402.102975
  14. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with singlephoton emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-489 https://doi.org/10.1093/eurheartj/ehm617
  15. Chung SY, Lee KY, Chun EJ, et al. Comparison of stress perfusion mri and spect for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. AJR Am J Roentgenol 2010;195:356-362 https://doi.org/10.2214/AJR.08.1839
  16. Harrigan CJ, Peters DC, Gibson CM, et al. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular mr imaging. Radiology 2011;258:128-133 https://doi.org/10.1148/radiol.10090526
  17. Sakamoto T, Amano K, Hada Y, et al. Asymmetric apical hypertrophy: ten years experience. Postgrad Med J 1986;62:567-570 https://doi.org/10.1136/pgmj.62.728.567
  18. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:638-645 https://doi.org/10.1016/S0735-1097(01)01778-8
  19. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;42:288-295 https://doi.org/10.1016/S0735-1097(03)00576-X
  20. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressureoverload hypertrophy. Circulation 1992;86:38-46 https://doi.org/10.1161/01.CIR.86.1.38
  21. Krams R, Kofflard M, Duncker D, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998; 97:230-233 https://doi.org/10.1161/01.CIR.97.3.230
  22. von Dohlen TW, Prisant LM, Frank MJ. Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 1989;64:498-503 https://doi.org/10.1016/0002-9149(89)90428-1
  23. Cannon RO 3rd, Dilsizian V, O'Gara PT, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660-1667 https://doi.org/10.1161/01.CIR.83.5.1660
  24. Lee KH, Jang HJ, Lee SC, et al. Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Int J Cardiovas Imaging 2003;19:381-388 https://doi.org/10.1023/A:1025807125699
  25. Panting JR, Gatehouse PD, Yang G-Z, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953 https://doi.org/10.1056/NEJMoa012369
  26. Lanza GA. Cardiac syndrome X: a critical overview and future perspectives. Heart 2007;93:159-166
  27. Yamada M, Elliott P, Kaski J, et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J 1998;19:500-507 https://doi.org/10.1053/euhj.1997.0769
  28. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:796-804 https://doi.org/10.1016/0735-1097(93)90193-5
  29. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-874 https://doi.org/10.1016/j.jacc.2010.05.010
  30. Cecchi F, Sgalambro A, Baldi M et al. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res 2009;2:452-461 https://doi.org/10.1007/s12265-009-9142-5